Rotella Capital Management, Inc. - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2015$85,000
+34.9%
43,666
+64.2%
0.07%
+27.3%
Q4 2014$63,000
+12.5%
26,588
+34.3%
0.06%
+17.0%
Q2 2014$56,000–19,800–0.05%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2015.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders